C Diff Foundation Welcomes Dr. David Cook, Ph.D.

Welcome cloud

We are pleased to welcome

Dr. David Cook,Ph.D.

joining the C Diff Foundation’s Research and Development Committee and Research Community.

David Cook is a scientist and entrepreneur who has held senior operating and management positions in the biotechnology industry over his 20-year career. Before joining Seres Health, he was the chief operating officer for the International AIDS Vaccine Initiative (IAVI), a global R&D organization whose mission is to develop a safe, globally accessible vaccine for HIV. Prior to IAVI, David was the founding CEO at Anza Therapeutics, a biotechnology start-up developing a novel microbial vaccine platform to induce cellular immune responses to fight or prevent diseases such as cancer, hepatitis C, malaria and tuberculosis. Before launching Anza, David held positions of increasing responsibility at the biotechnology corporations Cerus and Eligix, with oversight over R&D, program management, manufacturing, and clinical and regulatory affairs. He has led teams to develop and commercialize several biotech products and has been directly responsible for obtaining marketing authorization from the European Union for four novel medical products. He is also a co-inventor on over twenty-five patents. He received his undergraduate degree from Harvard College and his Ph.D. in chemistry from the University of California, Berkeley.